Archive - November 2024

In the competitive world of pharmaceuticals, innovators often employ complex strategies to maintain their market dominance. However, care must be taken to ensure that such strategies are not perceived to contravene the European Union’s competition rules, as a recent EU Commission decision shows. Teva is a pharmaceutical manufacturer which, until the expiration of the basic […]

The Supreme Court has today handed down its judgement in relation to the appeal from the Court of Appeal relating to infringement and validity of SKY trade marks. The judgement unanimously upholds the view of the High Court in finding that Sky had applied for the SKY marks in part in bad faith, because the […]